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Abstract Viral hemorrhagic diseases are a group of systemic
viral infections with worldwide distribution and are significant
causes of global mortality andmorbidity. The hallmarks of viral
hemorrhagic fevers are plasma leakage, thrombocytopenia,
coagulopathy and hemorrhagic manifestations. The molecular
mechanisms leading to plasma leakage in viral hemorrhagic
fevers are not well understood. A common theme has emerged
in which a complex interplay between pathogens, host immune
response, and endothelial cells leads to the activation of endo-
thelial cells and perturbation of barrier integrity. In this article,
two clinically distinct viral hemorrhagic fevers caused by den-
gue viruses and hantaviruses are discussed to highlight their
similarities and differences that may provide insights into the
pathogenesis and therapeutic approach.
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Introduction
Four families of viruses are known to cause viral hemorrhagic
diseases (VHFs): Flaviviridae, Bunyaviridae, Arenaviridae
and Filoviridae. These viruses are distributed worldwide and
are significant causes of global mortality and morbidity. The
severity of VHFs varies widely from minor bleeding to fatal
hemorrhagic fever characterized by plasma leakage and bleed-
ing, which may lead to circulatory failure. Distinct vascular
beds are involved in these diseases, resulting in different
clinical manifestations. Despite these differences, viral hem-
orrhagic fevers share common clinical and laboratory find-
ings, such as plasma leakage, hemoconcentration, thrombo-
cytopenia and coagulopathy. These similarities point to a
pathophysiological process shared by these conditions.
Since plasma leakage and bleeding are the hallmark of viral
hemorrhagic diseases, involvement of blood vessels and endo-
thelial cells in VHFs has been an active area of research. In
someVHFs, such as Ebolavirus and hantavirus infection, direct
infection of endothelial cells has been clearly demonstrated,
while in others, such as the dengue viruses (DENV), direct
infection of endothelial cells has been controversial. In addition
to direct viral effects, mediators produced by the host innate
immune system in response to viral genetic materials and
proteins and by host adaptive immune responses, play signifi-
cant roles in the pathogenesis of viral hemorrhagic fevers.
Although VHFs differ significantly in various clinical as-
pects, a common pathological process has emerged with re-
gard to the involvement of vascular endothelium and the
process leading to the perturbation of vascular barrier integrity
and coagulation abnormalities. Except for dengue, which is
endemic in many parts of the world with frequent major
outbreaks, most other VHFs occur sporadically as isolated
outbreaks. As such, detailed information about pathogenesis
is lacking for many VHFs. In this review, we will focus on 2
well-characterized but distinct VHFs: dengue virus and han-
tavirus infection. Similarities and differences between these
VHFs will be discussed to highlight common pathways and
mechanisms that may be shared among VHFs.
Agents
Dengue and hantaviruses are RNA viruses belonging to the
Flaviviridae and Bunyaviridae families, respectively. Other
than being RNA viruses, they do not share any other molecular
common features. Table 1 summarizes different aspects of den-
gue and hantavirus infections. Dengue viruses are a group of 4
serologically distinct RNA viruses: DENV1, DENV2, DENV3
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and DENV4. Their genomes are a 10-kb, single positive-
stranded RNA molecule that encodes 3 structural genes: enve-
lope (E), capsid (C) and preM (prM) proteins; and 7 nonstruc-
tural genes: NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5
(Gubler et al. 2007). The viral proteins are made as a single
polypeptide that is cleaved by both host and viral proteases,
yielding individual proteins. The envelope protein binds to host
cells and mediates viral uptake and entry (Kuhn et al. 2002). The
differences in the amino acid sequences of envelope proteins are
the basis for the serologically distinct dengue serotypes. The prM
protein on immature viral particles prevents fusion of the enve-
lope protein and cleavage of prM by a host enzyme, furin,
resulting in infectious mature particles (Junjhon et al.. 2008,
2010). Interestingly, DENV-infected cells release significant
amounts of immature particles that were previously believed to
be non-infectious (Junjhon et al. 2008, 2010). However, recent
studies have suggested that antibodies to DENV prM may
facilitate uptake of immature particles into host cells and enhance
viral uptake and replication during a secondary DENV infection
(Dejnirattisai et al. 2010; Rodenhuis-Zybert et al. 2010).
Nonstructural proteins play important roles in gene replication
and protein processing. In addition, several nonstructural pro-
teins, including NS1, NS2, NS4 and NS5, have been shown to
play important roles in immune evasion and pathogenesis of
dengue illness (Aguirre et al. 2012; Munoz-Jordan et al. 2005;
Yu et al. 2012).
Hantaviruses are a group of more than 30 related viruses
belonging to the Bunyaviridae family. They are broadly classi-
fied into Old World and New World hantaviruses, according to
geographical distribution (Hjelle and Torres-Perez 2010; Ksiazek
et al. 1995; Morzunov et al. 1998; Schmaljohn and Nichol 2007;
Spiropoulou et al. 1994). The Old World viruses are found in
Europe and Asia and cause hemorrhagic fever with renal syn-
drome (HFRS), while the New World viruses are found in the
Americas and cause hantavirus pulmonary syndrome (HPS).
Hantaviruses are enveloped RNA viruses with a 3-segment,
negative-sense RNA genome (Schmaljohn and Nichol 2007).
The term “negative-sense” refers to an RNA genome comple-
mentary to the messenger RNA that encodes the viral proteins.
The RNA segments are designated as small (S; 1,600–2,060 nt),
medium (M; ∼3,700 nt) and large (L; 6,500–7,000 nt). The S
segment encodes the nucleocapsid (N) protein, the L segment,
the polymerase L protein, the M segment and the 2 glycopro-
teins, Gn and Gc. The naked RNA genome is not infectious; an
infectious viral unit requires the viral RNA to be encapsidated
by N to form the nucleocapsid core and the presence of the L
polymerase protein. Both N and the 2 glycoproteins have been
implicated in suppressing the innate immune response during
early infection (Macneil et al. 2011). Some hantaviruses also
encode a single NS protein (NSs) in an overlapping second open
reading frame within the N coding region (Jaaskelainen et al.
2007; Plyusnin 2002; Spiropoulou et al. 1994). The role of NSs
has not been precisely defined but no apparent link betweenNSs
expression and hantavirus pathogenicity has been found.
Disease transmission and clinical manifestations
DENV and hantaviruses are quite distinct in their mode of
transmission. DENVare transmitted by mosquito vectors, Aedes
aegypti and, to a lesser extent, Ae. albopectus, while hantaviruses
are transmitted by inhalation of infectious rodent excreta (Gubler
Table 1 Similarities and differences between dengue hemorrhagic fever (DHF) and hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with
renal syndrome (HFRS)
DHF HPS/HFRS
Agent Dengue viruses New World hantavirus (HPS)
Old World hantavirus (HFRS)
Distribution Asia, Africa, Pacific, Americas Americas (HPS)
Asia, Europe (HFRS)
Genome 10-kb positive-strand RNA 11-kb negative-strand RNA
Transmission Mosquito bite Aerosol from rodent excreta
Limited human to human




Sites of plasma leakage Pleural and abdominal cavities Lungs (HPS), kidney (HFRS)
Mortality rate 1–5 % Up to 40 % (HPS)
5–15 % (HFRS)
Endothelial infection Unclear (in vivo) Severe
Endothelial pathology Minimal Minimal
Upregulated cytokines IFN-γ, IL-1, IL-6, IL-8, IL-10
IP-10, MCP-1, VEGF, angiopoietin 2
IFN- γ IL-6, IP-10, MCP-1, VEGF
Increased risk of severe disease with a previous exposure Yes No
Enhanced immune activation in severe disease Yes Yes
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et al. 2007; Schmaljohn and Hjelle 1997). Changes in local
weather patterns have been known to be associated with HPS
outbreaks due to increases in rodent vector populations (Nichol
et al. 1993; Schmaljohn and Hjelle 1997; Schmaljohn and
Nichol 2007). In addition, hantaviruses have been isolated from
other mammals, including shrews, moles and bats and these
animals may also serve as viral reservoirs. Behavioral and
ecological factors play important roles in the transmission of
DENV. Increased mosquito vector populations associated with
rapid urbanization have been considered an important factor
contributing to severe dengue illness outbreaks in Southeast
Asia after the Second World War (Gubler 1978). In addition,
changes in global weather patterns and increased human mo-
bility will likely further expand the areas affected by DENV.
DENVand hantavirus-caused illnesses share early clinical
presentations common to many viral infections: fever, myal-
gia, headache, nausea, vomiting and abdominal pain.
Maculopapular skin rash may be found in dengue illness
and helps in differential diagnosis against respiratory viral
infections. After 4–5 days of the prodromal phase, vascular
leakage, thrombocytopenia and coagulation abnormalities
occur. The locations of vascular leakage dictate the clinical
manifestations of these diseases. Plasma leakage in DENV
infection occurs in the pleural and abdominal cavities and in
severe cases may lead to volume depletion (Nimmannitya
1993; Trung and Wills 2010). In HPS, lung vessels are affect-
ed, resulting in pulmonary edema and respiratory failure
(Boroja et al. 2002; Castillo et al. 2001; Duchin et al. 1994;
Knust et al. 2012). With proper supportive treatment, patients
who survive this phase usually rapidly convalesce without
long-term sequelae. Infections with Old World hantaviruses
and Andes virus (ANDV) cause vascular leakage in the kid-
neys, manifested as proteinuria and hematuria that may lead to
acute renal failure. Similarly, the acute phase (or hypotensive
phase) is followed by a complete recovery in most cases.
Not all infected individuals experience severe disease. In
fact, asymptomatic and undifferentiated febrile illnesses are
common. This is particularly true for DENV infections. In
highly endemic areas, such as Southeast Asia, a primary
infection occurs early in life and is usually asymptomatic.
Subsequent infections with another serotype of DENV are
common, as the neutralizing antibodies to the primary infect-
ing virus do not effectively protect against other serotypes
(Halstead 2007). Secondary infections and primary infections
in older children and adults are associated with more severe
manifestations. Clinical dengue illness is classified into den-
gue fever (DF) and dengue hemorrhagic fever (DHF). By
defini t ion, plasma leakage only occurs in DHF
(Nimmannitya 1993). Hemorrhagic manifestations occur both
in DF and DHF but tend to be more severe in the latter. In the
past few years, another clinical case classification scheme has
been proposed, which classifies illnesses into dengue and
severe dengue (World Health Organization 2009). Severe
dengue is defined as dengue with (1) plasma leakage leading
to shock, (2) severe organ impairment and (3) severe hemor-
rhage. As this new classification is geared towards classifying
cases based on late and severe outcomes, which may reflect
combinations of factors not related to the underlying patholo-
gy, its applicability for pathogenesis research may be limited.
A number of host factors associated with severe disease in
dengue and HPS have been reported. Females tend to more
severely affected by both infections (Guerra-Silveira and
Abad-Franch 2013; Hjertqvist et al. 2010; Klein et al. 2011).
Host genetic polymorphisms at HLA and tumor necrosis
factor-α (TNF-α) gene loci that are associated with disease
severity have been reported in both conditions (Borges et al.
2010; Stephens 2010; Stephens et al. 2002). The HLA asso-
ciation is indicative of the role of T cell-mediated mechanisms
in pathogenesis. Other dengue illness severity-related poly-
morphisms include DC-SIGN (CD209), transporters associat-
ed with antigen presentation (TAPs), Fc receptor, cytotoxic
lymphocyte antigen 4 (CTLA4), mannose binding lectin-2
(MBL-2) and cytokine genes TNF-α, and TGF-β (Acioli-
Santos et al. 2008; Perez et al. 2010; Sakuntabhai et al. 2005).
Pathology
Limited human autopsy studies have been performed in den-
gue cases. The most often observed histological changes are
tissue edema and mild mononuclear cell infiltration
(Bhamarapravati et al. 1967; Fresh et al. 1969).
Hemorrhages, both microscopic and gross bleeding, are com-
mon findings in fatal dengue. The changes in vascular mor-
phology are generally unremarkable. Limited apoptosis of
endothelial cells has been reported in one study (Limonta
et al. 2007). The extent of hepatocellular injury varies among
studies. No definitive study has characterized infiltrating in-
flammatory cells in tissues. The primary pathology of HPS is
pulmonary edema. Accumulation of fluid in the alveoli and
mild to moderate interstitial infiltration with mononuclear
cells have been observed. Similar to dengue, morphologic
changes of the endothelium are uncommon, consisting pri-
marily of swollen endothelial cells (Zaki et al. 1995; Zaki et al.
1996). In both diseases, proliferation of lymphoid cells in the
spleen and lymph nodes is commonly observed.
Antigen staining and viral gene detection have demonstrat-
ed that endothelial cells of various organs can be infected with
hantaviruses (Nolte et al. 1995; Wang et al. 1997; Zaki et al.
1995). The extent of viral infection of endothelial cells corre-
lates with disease severity. As indicated above, no morpho-
logical changes were observed despite heavy infection. Lung
epithelial cells were not infected by hantaviruses and appeared
intact in HPS. In HFRS, however, viruses have been identified
in tubular cells of the kidneys (Groen et al. 1996). Other cells
in which hantaviruses have been located include follicular
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dendritic cells (FDC) and monocytes (Green et al. 1998;
Groen et al. 1996; Zaki et al. 1995). Studies of human tissue
from fatal dengue cases and from small animal models have
shown that monocytes, tissue macrophages and lymphocytes
express antigen and contain viral RNA (Balsitis et al. 2009;
Jessie et al. 2004). In contrast to hantaviruses, DENV have not
been definitely identified in endothelial cells. Although lung
alveolar endothelial cells and liver sinusoidal cells stain pos-
itive for DENV antigen, in situ hybridization did not demon-
strate viral RNA in these cells (Jessie et al. 2004).
Virus–host interaction and innate immune response
Virus interaction with host cell surface molecules results in
viral uptake and activation of the innate immune system.
Several molecules have been shown to interact with DENV.
Among these, the best characterized are 2 lectin molecules,
CD209 and CLEC5A (Chen et al. 2008; Tassaneetrithep et al.
2003). Both molecules bind DENV particles but CD209
probably plays a role in viral uptake, while binding of
DENV to CLEC5A results in production of pro-
inflammatory cytokines. Viral RNA is also detected in various
cellular compartments by TLRs and intracytoplasmic sensors,
such as RIG-I and MDA-5 (Nasirudeen et al. 2011;
Surasombatpattana et al. 2011). Activation of these pathways
leads to production of type I interferons (IFN) and proinflam-
matory cytokines, including IL-6, IL-8 and other chemokines.
Expression of certain DENV gene products, such as NS5 and
NS4, also activates production of pro-inflammatory cytokines
through the NF-κB pathway in various cell types, including
lung epithelial cells, monocytes and human umbilical vein
endothelial cells (HUVEC) (Bosch et al. 2002; Kelley et al.
2012; Medin et al. 2005). Mediators produced by these cells
may play a role in altered vascular permeability in dengue.
Hantaviruses use β3 and β1 integrins and CD55 as their
cellular receptors (Gavrilovskaya et al. 1998). Interaction
between hantaviruses and β3 integrins has been implicated
in altered permeability by enhancing the response to vascular
endothelial growth factor (VEGF) (Gorbunova et al. 2010).
Pathogenic hantaviruses have developed multiple mecha-
nisms to evade the early host innate immune response and
inhibit the induction of type 1 IFN in infected cells, allowing
efficient viral replication and spread. One way in which han-
taviruses avoid activating type I IFN pathways is by using a
prime and realign transcription mechanism that results in viral
RNA transcripts possessing a terminal 5′ monophosphate
instead of 5′ triphosphate (Garcin et al. 1995; Habjan et al.
2008; Handke et al. 2009). In addition, hantavirus glycopro-
teins and N protein can inhibit IFN signaling, either by direct-
ly inhibiting RIG-I and IRF-3 activation or by inhibiting
STAT1 and STAT2 phosphorylation and nuclear translocation
(Alff et al. 2008; Levine et al. 2010; Spiropoulou et al. 2007).
The N protein has also been implicated in inhibiting inflam-
matory responses by blocking the import of NF-κB to the
nucleus (Taylor et al. 2009a). This inhibition seems to be
characteristic of the Old World pathogenic hantaviruses
(Taylor et al. 2009b).
Hantaviruses can infect a variety of cell types, including
endothelial cells, tissue macrophages, dendritic cells (DC) and
renal tubular cells (Krautkramer et al. 2011;Markotic et al. 2007;
Pensiero et al. 1992; Raftery et al. 2002). Infection of endothelial
cells induces production of numerous cytokines, including
monocyte chemoattractant protein (MCP-1), regulated upon ac-
tivation, normal T cell expressed and secreted (RANTES) and
IFNγ-induced protein 10 (IP-10) (Sundstrom et al. 2001).
Primary humanDC infected with hantaviruses in vitro are quick-
ly activated and secrete pro-inflammatory cytokines like TNF-α
and an active form of matrix metalloprotease 9 (MMP-9)
(Marsac et al. 2011; Raftery et al. 2002). In both DENV and
hantavirus infections, DC and monocytes/macrophages are pos-
sibly the initial sites of viral replication, contributing to the
subsequent viremia and infection of other cell types. Based on
available in vivo data, infection of other cell types, including
endothelial cells, seems to be limited in DENV infection. In
contrast, exuberant infection of endothelial cells is typical in
hantavirus infections (Zaki et al. 1995). The interaction between
host cells and the pathogens and their products induces both an
antiviral response through type I IFN and a pro-inflammatory
response through various cytokines and chemokines. These me-
diators are not only critical in elaborating antigen-specific adap-
tive immunity but also directly contribute to endothelial cell
activation, leading to integrity perturbation and coagulopathy
observed in these VHFs.
Direct effects of DENVand hantavirus on endothelial cells
The established paradigm proposes that vascular endothelium
dysfunction upon hantavirus and DENVinfection is based large-
ly on immune modulation. However, recent studies have sug-
gested that direct viral effects may contribute to altered endothe-
lial functions. These studies are based on the findings that virus
infection alone can cause a loss of integrity of the vascular
endothelium by causing secretion of permeability factors.
Infection of human primary lung endothelial cells with HPS-
associated hantaviruses has resulted in increased permeability
and loss of endothelial cell barrier integrity (Shrivastava-Ranjan
et al. 2010). VEGF-R2 andVE-cadherinmaintain the endothelial
cell barrier (Lampugnani et al. 2006). VEGF binding to VEGF-
R2 causes its activation and dimerization, thereby initiating the
internalization and degradation of VE-cadherin and disruption of
adherens junctions (Gavard and Gutkind 2006; Xiao et al. 2003).
Consistent with this process, antibody blockage of VEGF-R2
activation inhibited hantavirus-induced VE-cadherin reduction.
However, in a recently developed in vitro capillary blood vessel
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model, in which endothelial cells and vascular smooth muscle
cells were co-cultured, secreted VEGF was detected but VE-
cadherin degradation was not observed (Taylor et al. 2013). This
model demonstrated, instead, a role for bradykinin, a potent
inflammatory peptide, in hantavirus-induced capillary leakage.
It is possible that both VEGF and bradykinin could work syner-
gistically to increase vascular permeability in hantavirus-infected
cells.
The most prominent cellular response to hantavirus infec-
tion is induction of hyper-permeability of the microvascular
endothelium. This has been shown initially by the exogenous
addition of TNF-α to hantavirus-infected endothelium
(Niikura et al. 2004). More recently, a number of in vitro
studies have shown that adding VEGF to primary endothelial
cell monolayers infected with pathogenic hantaviruses acti-
vates VEGF-R2 and Src kinase, leading to VE-cadherin inter-
nalization and degradation and induction of hypermeability
(Gavrilovskaya et al. 2008; Gorbunova et al. 2010, 2011).
Adding factors like angiopoietin-1 and sphingosine-1-
phosphate (S1P), which inhibit VEGF-R2 induced permeabil-
ity, blocked VE-cadherin internalization in response to VEGF
(Gavard and Gutkind 2006; Gavrilovskaya et al. 2008;
Gorbunova et al. 2011).
In contrast to hantaviruses, DENV infection of the vascular
endothelium has not been well documented in vivo. DENV
antigen has been identified in endothelial cells in the lungs, liver
and spleen in humans and experimental mouse models.
However, conclusive evidence of DENV infection in human
endothelial cells is still lacking. Histopathology studies of fatal
dengue cases have demonstrated cell edema and limited
pyknosis. In vitro, DENV can infect endothelial cells, resulting
in the production of chemokines, including IL-8, RANTES
and monocyte chemoattractant protein-1 (MCP-1).
Additionally, increased cell surface expression of ICAM-1,
β3 integrin and VEGF-R2 has been reported (Srikiatkhachorn
et al. 2007; Zhang et al. 2007). Studies examining direct effects
of DENV on endothelial permeability have shown conflicting
results. Elevated circulating levels of soluble surface molecules
expressed by endothelial cells, such as soluble intercellular
adhesion molecule (sICAM-1) and vascular cell adhesion mol-
ecule (sVCAM-1), have been reported and are indicative of
in vivo activation of endothelial cells. In addition to direct viral
effects, endothelial permeability can also be altered by interac-
tions between DENV-infected monocytes and dendritic cells
via effects of TNF-α and metalloproteinase enzymes secreted
by these cells (Carr et al. 2003; Kelley et al. 2012; Lee et al.
2006; Luplertlop et al. 2006).
The role of adaptive immunity
The role of adaptive immunity in disease progression has been
demonstrated in both DENV- and hantavirus-induced human
diseases. This adaptive immunity is characterized by the acti-
vation of antigen-specific CD4+/CD8+ T cells and B cells. A
robust T cell response is generated in humans during hantavi-
rus infection and is followed by a long-lived memory T cell
response (Van Epps et al. 2002). Several CD4+ and CD8+ T
cell clones obtained from the blood of acute and convalescent
HPS patients recognize epitopes from N, Gn and Gc viral
proteins (Ennis et al. 1997; Kilpatrick et al. 2004; Terajima
et al. 2004; Van Epps et al. 1999). Higher frequencies of Sin
Nombre virus-specific CD8+ T cells have been detected in
patients with severe HPS than in patients with less severe
symptoms (Kilpatrick et al. 2004). These are all strong indi-
cations that virus-specific CD8+ T cells play a key role in
virus-induced immunopathology (Terajima and Ennis 2011).
Other studies indicate that long-lived effector memory T cell
responses may contribute to protective immunity in ANDV-
infected patients (Manigold et al. 2010; Prescott et al. 2013). T
cell depletion has no effect on disease outcome in the hamster
model of HPS (Hammerbeck and Hooper 2011; Prescott et al.
2013). This argues that induction of HPS, at least in the
hamster model, is not based on virus-induced immune mod-
ulation. Additionally, NK cells are rapidly expanded and
remain elevated for a considerable time after human hantavi-
rus infection (Bjorkstrom et al. 2011).
Hantaviruses induce a long-lasting humoral immune re-
sponse (Settergren 1991). Antibodies to hantaviral N protein
are present in the serum of patients soon after the onset of
disease, quickly followed by neutralizing antibodies directed
against viral glycoproteins (Jenison et al. 1994; Lundkvist
et al. 1997; Valdivieso et al. 2006). High titers of neutralizing
antibodies in the patient serum correlate with milder disease
outcomes (Bharadwaj et al. 2000; MacNeil et al. 2010).
The role of adaptive immunity in the pathogenesis of
dengue is indicated by the increased risk of severe disease
during a secondary DENV infection. Enhanced viral uptake
and replication by cross-reactive non-neutralizing antibodies
specific to the previously exposed DENV structural proteins,
such as prM or E proteins, may lead to increased antigen load
and enhanced immune activation. Consistent with this notion,
higher levels of viremia and viral RNA have been associated
with DHF (Libraty et al. 2002a, b; Srikiatkhachorn et al. 2012;
Vaughn et al. 2000). Further, studies have demonstrated
higher frequencies of DENV-specific T cells (quantified using
tetramer staining and functional assays) and increased expres-
sion of activation markers in DHF in comparison to DF
(Green et al. 1999a; Mongkolsapaya et al. 2003).
Enumeration of DENV-specific T cells using HLA-peptide
tetramer has revealed that CD8+ T cells specific to the newly
exposed DENVand to previously exposed DENVare expand-
ed during a secondary infection. Interestingly, cross-reactive
memory T cells were preferentially expanded during a sec-
ondary infection. Functional analyses of these cross-reactive T
cells have demonstrated distinct patterns of cytokine
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production upon activation by epitope peptides corresponding
to the amino acid sequences found in the infecting or previ-
ously exposed DENV (Bashyam et al. 2006; Friberg et al.
2011; Mangada and Rothman 2005). Ex vivo analyses of T
cells from dengue patients revealed decreased expression of
degranulation marker (a marker for cytolytic activity) and
increased cytokine production when cross-reactive memory
T cells were stimulated with epitope peptides of the infecting
DENV serotype (Mongkolsapaya et al. 2006). The decreased
cytolytic activity and enhanced cytokine response may play a
critical role in the loss of vascular integrity, leading to plasma
leakage.
DENV-specific antibodies may play dual roles in protec-
tion against and exacerbation of severe disease. Serotype-
specific antibodies have long been thought to be important
in protection against subsequent infections. Higher neutraliz-
ing antibody titers were associated with milder disease in
subsequent infections in a cohort study (Endy et al. 2004).
However, the lack of protection despite the presence of neu-
tralizing antibodies demonstrated in a recent vaccine trial has
called into the question the role of neutralizing antibodies and
the ways by which these antibodies are measured; it is unclear
whether they reflect protective immunity (Sabchareon et al.
2012). As previously stated, sub-neutralizing levels of anti-
bodies against DENVenvelope protein and antibodies to prM
could enhance viral uptake and replication in vitro. In addi-
tion, a series of studies have shown that DENV-specific anti-
bodies exhibited cross-reactivity against a number of host
antigens, including H+-transporter/ATP synthase, protein di-
sulfide isomerase (PDI), vimentin, heat shock protein 60,
fibrinogen and plasminogen (Chuang et al. 2011; Lin et al.
2011; Liu et al. 2011) and have been implicated in the
pathogensis of dengue by inducing abnormal activation and
functions of platelets and endothelial cells, leading to endo-
thelial cell apoptosis and hemorrhage in experimental animals
(Falconar 1997; Sun et al. 2007). The role of these antibodies
in the pathogenesis of human dengue infection is unclear,
since autoimmune manifestations are not observed after re-
covery from dengue, when these antibodies should persist
beyond the acute illness period.
Cytokines and angiogenic factors relevant in VHFs
High levels of cytokines have been detected in the plasma and
serum or pleural effusions of patients infected with hantavirus
or DENV (Borges et al. 2008; Mori et al. 1999). DENV-
infected monocytes and DC produce a number of mediators,
such as IL-6, IL-8 and IFN-γ-inducible chemokines CXCL9,
CXCL10 and CXCL11, all of which have permeability-
enhancing and chemoattractant properties (Bosch et al.
2002; Dejnirattisai et al. 2008). Immunomodulatory cytokine
IL-10 can be produced by DENV-infected monocytes and
DC and elevated IL-10 levels have been reported in DHF
patients (Green et al. 1999b; Ubol et al. 2010). One cytokine
of special interest is TNF-α, a permeability-enhancing and
pro-coagulation factor. While it has been extensively studied,
reports on TNF-α levels in severe DENV infection are con-
flicting (Azeredo et al. 2006; Braga et al. 2001). Enhanced
activation of DENV-specific T cells likely contributes to the
elevated cytokine levels in DHF. Multiple cytokines are se-
creted by DENV-specific T cells, including Th1 type cyto-
kines IL-2, IFN-γ, TNF-α and various chemokines
(Bashyam et al. 2006; Mangada and Rothman 2005).
Indeed, elevated levels of both Th1-type (IFN-γ) and Th2-
type cytokines (IL-4, IL-13, IL-10) have been reported in
DHF (Bozza et al. 2008; Butthep et al. 2012). Primary human
monocytes and DC infected with hantaviruses in vitro are
quickly activated and secrete a number of pro-inflammatory
cytokines, including TNF-α (Cebalo and Markotic 2007;
Markotic et al. 2007; Marsac et al. 2011; Raftery et al.
2002). In vitro studies have also shown the induction of
chemokines, such as MCP-1, RANTES and IP-10, in
hantavirus-infected vascular endothelium (Geimonen et al.
2002; Khaiboullina and St Jeor 2002; Sundstrom et al.
2001). These chemokines can recruit immune cell infiltrates
into the lung and other organs. Based on immunocytochemi-
cal studies, several cytokines have been detected in patients
with severe hantavirus disease; these cytokines are potentially
produced by T cells and include TNF-α, IL-2, IL-6 and
Fig. 1 Possible mechanism of plasma leakage in DHF and HPS. a
DENV-infected monocytes and dendritic cells release cytokines, such
as TNF-α and chemokines (IL-8,MCP-1), resulting in increased vascular
permeability and recruitment of inflammatory cells. Activated T cells
may release permeability enhancing mediators, including IL-2, IFN-γ,
TNF-α and the chemokines. Elevated VEGF levels may be secondary to
VEGF produced by monocytes, T cells, or endothelial cells. In addition,
infection of endothelial cells has been shown to suppress the production
of soluble VEGFR2 and to increase surface receptor expression, leading
to enhanced responsiveness to VEGF. Other potential mechanisms, not
depicted, include deposition of antigen-antibody complexes and comple-
ment activation on endothelial cell surface and autoantibodies that react
to endothelial cells. The net effect is the leakage of albumin-rich fluid into
serosal cavities. b Hantavirus accesses the vascular endothelium via
infected DC and/or infected alveolar macrophages. Early post-infection,
the virus inhibits induction of type 1 IFN in infected cells, allowing
efficient viral replication and spread. Hantavirus-infected endothelial
cells produce proinflammatory cytokines and chemokine, and upregu-
late adhesion molecules on their cell surface, attracting monocytes,
macrophages and T cells. In addition, the infected endothelium can
release bradykinin, which can directly increase vascular permeability.
Binding of the virus to β3 integrins on endothelial cells, along with the
early secretion of VEGF, could trigger the disruption of adherens junc-
tions and downregulation of VE-cadherin. Accumulation of hantavirus-
infected monocytes, macrophages and T cells in the vicinity of the
endothelium can result in exuberant release of cytokines, chemokines
and permeability factors like TNF-α and VEGF. Additional VEGF could
be secreted by ANDV-activated platelets. TNF-α and VEGF from these
sources could reach high concentrations in the microvasculature of the
lung, resulting in vascular hyper-permeability and leakage

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IFN-γ (Mori et al. 1999; Temonen et al. 1996). Both TNF-α
and IL-2 can increase vascular permeability.
Changes in circulating levels of angiogenic factors, includ-
ing VEGF, its soluble receptors VEGF-R1 and VEGF-R2 and
angiopoietin-1 and angiopoietin-2 have been reported to cor-
relate with DENV disease severity (Michels et al. 2012;
Srikiatkhachorn et al. 2007). Notably, increased VEGF-R2
expression has been associated with an enhanced response to
VEGF by DENV-infected endothelial cells (Srikiatkhachorn
et al. 2007). In support of this notion, a similar pro-leakage
angiogenic profile of elevated levels of angiopoietin-2 and
low levels of angiopoietin-1 has been seen in other conditions
with plasma leakage, such as sepsis and correlates with
severity and outcomes (Parikh et al. 2006; Ricciuto et al.
2011). Increased levels of free VEGF have also been reported
in sera from hantavirus patients (Gavrilovskaya et al. 2012;
Ma et al. 2012; Shrivastava-Ranjan et al. 2010) and low levels
of angiopoietin-1 have been seen in HFRS patient sera
(Hwang et al. 2009). Endothelial cell activation, marked by
elevated levels of circulating soluble surface molecules
expressed by endothelial cells, such as soluble intercellular
adhesion molecule 1 (sICAM-1) and soluble vascular cell adhe-
sion molecule (sVCAM-1), has been detected in both DHF and
HFRS human sera (Han et al. 2010).
The contribution of these permeability-regulating cyto-
kines in the pathogenesis of hantavirus disease and DHF is
not clear. The conflicting results in cytokine level data in
hantavirus and DENV infection may be due to the heteroge-
neity in study designs, times of sample collection, differences
in patient populations and clinical classification. An addition-
al difficulty in interpreting studies of hantaviral diseases,
particularly HPS, is the small number of samples available
for such analysis. The roles of these mediators in the manifes-
tations of these infections can only be definitely tested in
animal models. Notably, a study using a mouse model of
DENV infection has demonstrated that in vivo neutralization
of TNF-α prevented death in this model. Whether this is
relevant to human dengue illness is not clear, since these small
animal models do not faithfully reproduce the clinical picture
of human DHF.
Endothelial cell-based therapeutic intervention
Considering that microvascular leakage is a common factor
that correlates with disease severity for both hantaviruses and
DENV, it is reasonable to assume that treatments that block
vascular permeability could be used to treat the diseases
caused by these viruses. Several agents that enhance endothe-
lial barrier integrity have been used in tissue culture experi-
ments of hantavirus infections. Some of these agents are small
molecule anti-angiogenic agents, like Pazopanib and
Dasatinib, which prevent ANDV-induced hyper-permeability
by blocking VEGF-R2 or Src kinase (Gorbunova et al. 2011).
An alternative approach is to strengthen the infected vascular
barrier by activating Roundabout homolog 4 (Robo-4)-depen-
dent signaling pathways using the soluble ligand Slit-2
(Gorbunova et al. 2013). Based on recent reports, small mol-
ecules preventing activation of the plasma kallikrein–kinin
system and bradykinin release could also be used to treat
hantavirus diseases (Taylor et al. 2013).
Studying the importance of vascular leakage in hantavirus
and DENV infections, as well as determining the efficacy of
anti-leakage treatments for these diseases, would be facilitated
by the use of animal disease model experiments. The absence
of appropriate animal models mimicking human DENV dis-
ease progression is a major limitation of such studies. Recent
studies using immunocompromised mice and/or mouse-
adapted DENV have implicated TNF-α in mediating plasma
leakage and hemorrhage, possibly through the production of
reactive oxygen species (Shresta et al. 2006; Wu-Hsieh et al.
2009). Currently, the only small animal model for hantavirus
disease is infection of Syrian golden hamsters with two South
America hantaviruses, ANDV and Maporal virus (Hooper
et al. 2001; Milazzo et al. 2002). Infecting hamsters with these
viruses results in disease with characteristics similar to those
of human HPS, including interstitial pneumonitis and micro-
vascular leakage. No small animal model exists for HFRS,
though HFRS-like illness has been observed in cynomolgus
macaques infected with a Puumala virus strain that was
propagated in the rodent host and not tissue culture-adapted
(Klingstrom et al. 2002; Sironen et al. 2008). Currently,
in vivo experiments using small molecule tyrosine kinase
inhibitors have been initiated in hantavirus-infected hamsters
(Dolgin 2012). Of note, a successful treatment of one patient
with a single dose of icatibant, a bradykinin receptor antago-
nist, has been recently reported (Antonen et al. 2013).
Conclusion and perspectives
Although distinct vascular beds are affected in DHF and HPS,
leading to different clinical manifestations, these two VHFs
share certain clinical features and pathophysiologic processes.
Endothelial cell activation and dysfunction, perturbation of
barrier integrity and activation of coagulation pathways are
common in both diseases. In both conditions, the complex
interplay between the viruses, the immune systems and the
endothelial cells determines the activation of endothelial cells
and the functional consequences (Fig. 1). Insights into the
common and distinct molecular mechanisms of these condi-
tions will be important for the development of treatment and
preventive measures against them.
Due to the lack of animal models, the understanding of
disease mechanisms in dengue illness and HPS has been largely
derived from human studies. However, conflicting findings are
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common. The dynamic patterns of cytokines/biological media-
tors relative to the clinical course require that sample collection
be performed at certain time points and the findings interpreted in
the context of the clinical course. In addition, differences in
sample collection methods can affect the levels of mediators in
these samples, resulting in inconsistent findings. Small numbers
of cases (in the case of HPS) and the limited sample volume,
particularly from children infected with DENV, are additional
limitations in human studies. Despite these limitations, well-
planned prospective studies remain necessary in an ef-
fort to gain further insights into the pathogenesis of
these diseases. The recent development of small animal
models for both dengue VHF and HPS is an important
advance. However, further improvement in these models
to more closely mimic human diseases will be needed.
Nevertheless, such animal models will be critical in the
evaluation of therapeutic measures to ameliorate severe
clinical manifestations, particularly plasma leakage and
hemorrhage, the major causes of VHF fatality.
Acknowledgements The findings and conclusions in this report are
those of the authors and do not necessarily represent those of the Centers
for Disease Control and Prevention. Part of this work was supported by
National Institutes of Health Grant NIH-P01AI34533. The opinions or
assertions contained herein are the private ones of the authors and are not
to be construed as official or reflecting the view of the US Government.
The authors thank Craig Manning for help with the illustration.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License, which permits any use, distribution and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
Acioli-Santos B, Segat L, Dhalia R, Brito CA, Braga-Neto UM,Marques
ET, Crovella S (2008) MBL2 gene polymorphisms protect against
development of thrombocytopenia associated with severe dengue
phenotype. Hum Immunol 69:122–128
Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D,
Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-
Madoz JR, Mulder LC, Barber GN, Fernandez-Sesma A (2012)
DENV inhibits type I IFN production in infected cells by cleaving
human STING. PLoS Pathog 8:e1002934
Alff PJ, Sen N, Gorbunova E, Gavrilovskaya IN,Mackow ER (2008) The
NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and
inhibits cellular interferon responses by disrupting TBK1-TRAF3
complex formation. J Virol 82:9115–9122
Antonen J, Leppanen I, Tenhunen J, Arvola P, Makela S, Vaheri A,
Mustonen J (2013) A severe case of Puumala hantavirus infection
successfully treated with bradykinin receptor antagonist icatibant.
Scand J Infect Dis 45:494–496
Azeredo EL, Zagne SM, Alvarenga AR, Nogueira RM, Kubelka CF, de
Oliveira-Pinto LM (2006) Activated peripheral lymphocytes with
increased expression of cell adhesion molecules and cytotoxic
markers are associated with dengue fever disease. Mem Inst
Oswaldo Cruz 101:437–449
Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH,
Beatty PR, Harris E (2009) Tropism of dengue virus in mice and
humans defined by viral nonstructural protein 3-specific immuno-
staining. Am J Trop Med Hyg 80:416–424
BashyamHS, Green S, RothmanAL (2006)Dengue virus-reactive CD8+
T cells display quantitative and qualitative differences in their re-
sponse to variant epitopes of heterologous viral serotypes. J
Immunol 176:2817–2824
Bhamarapravati N, Tuchinda P, Boonyapaknavik V (1967) Pathology of
Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann
Trop Med Parasitol 61:500–510
Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B (2000)
Humoral immune responses in the hantavirus cardiopulmonary
syndrome. J Infect Dis 182:43–48
Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M,
Michaelsson J,Malmberg KJ, Klingstrom J, AhlmC, LjunggrenHG
(2011) Rapid expansion and long-term persistence of elevated NK
cell numbers in humans infected with hantavirus. J Exp Med 208:
13–21
Borges AA, Campos GM, Moreli ML, Moro Souza RL, Saggioro FP,
FigueiredoGG, LivonesiMC,Moraes Figueiredo LT (2008) Role of
mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis
of hantavirus pulmonary syndrome.Microbes Infect Inst Pasteur 10:
1150–1157
Borges AA, Donadi EA, Campos GM, Moreli ML, de Sousa RL,
Saggioro FP, de Figueiredo GG, Badra SJ, Deghaide NH,
Figueiredo LT (2010) Association of -308G/A polymorphism in
the tumor necrosis factor-alpha gene promoter with susceptibility
to development of hantavirus cardiopulmonary syndrome in the
Ribeirao Preto region, Brazil. Arch Virol 155:971–975
Boroja M, Barrie JR, Raymond GS (2002) Radiographic findings in 20
patients with Hantavirus pulmonary syndrome correlated with clin-
ical outcome. AJR Am J Roentgenol 178:159–163
Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier
MV, Ennis FA, Rothman AL (2002) Increased production of
interleukin-8 in primary human monocytes and in human epithelial
and endothelial cell lines after dengue virus challenge. J Virol 76:
5588–5597
Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF,
Bozza PT, Kubelka CF (2008) Multiplex cytokine profile from
dengue patients: MIP-1beta and IFN-gamma as predictive factors
for severity. BMC Infect Dis 8:86
Braga EL, Moura P, Pinto LM, Ignacio SR, Oliveira MJ, Cordeiro MT,
Kubelka CF (2001) Detection of circulant tumor necrosis factor-
alpha, soluble tumor necrosis factor p75 and interferon-gamma in
Brazilian patients with dengue fever and dengue hemorrhagic fever.
Mem Inst Oswaldo Cruz 96:229–232
Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A
(2012) Alteration of cytokines and chemokines during febrile epi-
sodes associated with endothelial cell damage and plasma leakage in
dengue hemorrhagic Fever. Pediatr Infect Dis J 31:e232–e238
Carr JM, Hocking H, Bunting K, Wright PJ, Davidson A, Gamble J,
Burrell CJ, Li P (2003) Supernatants from dengue virus type-2
infected macrophages induce permeability changes in endothelial
cell monolayers. J Med Virol 69:521–528
Castillo C, Naranjo J, Sepulveda A, Ossa G, Levy H (2001) Hantavirus
pulmonary syndrome due to Andes virus in Temuco, Chile: clinical
experience with 16 adults. Chest 120:548–554
Cebalo L,MarkoticA (2007)Chemokine production predominates in human
monocytes infected with Tula virus. Viral Immunol 20:206–213
Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK,
Chiou TW, Wong CH, Hsieh SL (2008) CLEC5A is critical for
dengue-virus-induced lethal disease. Nature 453:672–676
Chuang YC, Lei HY, Lin YS, Liu HS, Wu HL, Yeh TM (2011) Dengue
virus-induced autoantibodies bind to plasminogen and enhance its
activation. J Immunol 187:6483–6490
Cell Tissue Res (2014) 355:621–633 629
Dejnirattisai W, Duangchinda T, Lin CL, Vasanawathana S, Jones M,
Jacobs M, Malasit P, Xu XN, Screaton G, Mongkolsapaya J (2008)
A complex interplay among virus, dendritic cells, T cells, and
cytokines in dengue virus infections. J Immunol 181:5865–5874
Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana
S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa
S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G
(2010) Cross-reacting antibodies enhance dengue virus infection in
humans. Science 328:745–748
Dengue, guidelines for diagnosis, treatment, prevention and control
(2009). Switzerland:World Health Organization, Geneva
Dolgin E (2012) Hantavirus treatments advance amidst outbreak in US
park. Nat Med 18:1448
Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR,
Ksiazek TG, Rollin PE, Nichol S, Umland ET et al (1994)
Hantavirus pulmonary syndrome: a clinical description of 17 pa-
tients with a newly recognized disease. The Hantavirus Study
Group. N Engl J Med 330:949–955
Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA,
Rothman AL, Libraty DH (2004) Relationship of preexisting den-
gue virus (DV) neutralizing antibody levels to viremia and severity
of disease in a prospective cohort study of DV infection in Thailand.
J Infect Dis 189:990–1000
Ennis FA, Cruz J, Spiropoulou CF,Waite D, Peters CJ, Nichol ST, Kariwa
H, Koster FT (1997) Hantavirus pulmonary syndrome: CD8+ and
CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus
nucleocapsid protein isolated during acute illness. Virology 238:
380–390
Falconar AK (1997) The dengue virus nonstructural-1 protein (NS1)
generates antibodies to common epitopes on human blood clotting,
integrin/adhesin proteins and binds to human endothelial cells:
potential implications in haemorrhagic fever pathogenesis. Arch
Virol 142:897–916
Fresh JW, Reyes V, Clarke EJ, Uylangco CV (1969) Philippine hemor-
rhagic fever: a clinical, laboratory, and necropsy study. J Lab Clin
Med 73:451–458
Friberg H, Burns L, Woda M, Kalayanarooj S, Endy TP, Stephens HA,
Green S, Rothman AL, Mathew A (2011) Memory CD8+ T cells
from naturally acquired primary dengue virus infection are highly
cross-reactive. Immunol Cell Biol 89:122–129
Garcin D, Lezzi M, Dobbs M, Elliott RM, Schmaljohn C, Kang CY,
Kolakofsky D (1995) The 5' ends of Hantaan virus (Bunyaviridae)
RNAs suggest a prime-and-realign mechanism for the initiation of
RNA synthesis. J Virol 69:5754–5762
Gavard J, Gutkind JS (2006) VEGF controls endothelial-cell permeability
by promoting the beta-arrestin-dependent endocytosis of VE-
cadherin. Nat Cell Biol 8:1223–1234
Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER
(1998) beta3 Integrins mediate the cellular entry of hantaviruses that
cause respiratory failure. Proc Natl Acad Sci USA 95:7074–7079
Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER (2008)
Hantaviruses direct endothelial cell permeability by sensitizing cells
to the vascular permeability factor VEGF, while angiopoietin 1 and
sphingosine 1-phosphate inhibit hantavirus-directed permeability. J
Virol 82:5797–5806
Gavrilovskaya I, Gorbunova E, Koster F, Mackow E (2012) Elevated
VEGF levels in pulmonary edema fluid and PBMCs from patients
with acute hantavirus pulmonary syndrome. Adv Virol 2012:674360
Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow
ER (2002) Pathogenic and nonpathogenic hantaviruses differential-
ly regulate endothelial cell responses. Proc Natl Acad Sci USA 99:
13837–13842
Gorbunova E, Gavrilovskaya IN, Mackow ER (2010) Pathogenic hanta-
viruses Andes virus and Hantaan virus induce adherens junction
disassembly by directing vascular endothelial cadherin internaliza-
tion in human endothelial cells. J Virol 84:7405–7411
Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER (2011)
VEGFR2 and Src kinase inhibitors suppress Andes virus-induced
endothelial cell permeability. J Virol 85:2296–2303
Gorbunova EE, Gavrilovskaya IN, Mackow ER (2013) Slit2-Robo4
receptor responses inhibit ANDV directed permeability of human
lung microvascular endothelial cells. Antivir Res 99:108–112
GreenW, Feddersen R, Yousef O, Behr M, Smith K, Nestler J, Jenison S,
Yamada T, Hjelle B (1998) Tissue distribution of hantavirus antigen
in naturally infected humans and deer mice. J Infect Dis 177:1696–
1700
Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S,
Nisalak A, Kurane I, Rothman AL, Ennis FA (1999a) Early CD69
expression on peripheral blood lymphocytes from children with
dengue hemorrhagic fever. J Infect Dis 180:1429–1435
Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S,
Nisalak A, Rothman AL, Ennis FA (1999b) Elevated plasma
interleukin-10 levels in acute dengue correlate with disease severity.
J Med Virol 59:329–334
Groen J, Bruijn JA, Gerding MN, Jordans JG, Moll van Charante AW,
Osterhaus AD (1996) Hantavirus antigen detection in kidney biop-
sies from patients with nephropathia epidemica. Clin Nephrol 46:
379–383
Gubler D (1978) Factors influencing the distribution and spread of
epidemic dengue haemorrhagic fever. Asian J Infect Dis 2:128–131
Gubler D, Kuno G, Markoff L (2007) Flavivirus, Field's Virology.
Lippincott Williams & Wilkins, Philadelphia
Guerra-Silveira F, Abad-Franch F (2013) Sex bias in infectious disease
epidemiology: patterns and processes. PLoS ONE 8:e62390
Habjan M, Andersson I, Klingstrom J, Schumann M, Martin A,
Zimmermann P, Wagner V, Pichlmair A, Schneider U, Muhlberger
E, Mirazimi A,Weber F (2008) Processing of genome 5' termini as a
strategy of negative-strand RNA viruses to avoid RIG-I-dependent
interferon induction. PLoS ONE 3:e2032
Halstead SB (2007) Dengue. Lancet 370:1644–1652
Hammerbeck CD, Hooper JW (2011) T cells are not required for patho-
genesis in the syrian hamster model of hantavirus pulmonary syn-
drome. J Virol 85(19):9929–9944
Han Q, Zhang L, Liu Z, Kang W, Lou S, Qiu J, Li Z, Zhang G, Wang Y,
Li M, Li N (2010) Elevated sICAM-1 levels in patients with hem-
orrhagic fever with renal syndrome caused by Hantaan virus. Eur J
Clin Microbiol Infect Dis 29:1507–1511
Handke W, Oelschlegel R, Franke R, Kruger DH, Rang A (2009)
Hantaan virus triggers TLR3-dependent innate immune responses.
J Immunol 182:2849–2858
Hjelle B, Torres-Perez F (2010) Hantaviruses in the americas and their
role as emerging pathogens. Viruses 2:2559–2586
Hjertqvist M, Klein SL, Ahlm C, Klingstrom J (2010) Mortality rate
patterns for hemorrhagic fever with renal syndrome caused by
Puumala virus. Emerg Infect Dis 16:1584–1586
Hooper JW, Larsen T, Custer DM, Schmaljohn CS (2001) A lethal disease
model for hantavirus pulmonary syndrome. Virology 289:6–14
Hwang JY, Park JW, Hong SY, Park HS (2009) Reduced expression of
angiopoietin-1 in Hantaan virus-infected human umbilical vein en-
dothelial cell increases their permeability. Acta Virol 53:7–13
Jaaskelainen KM, Kaukinen P, Minskaya ES, Plyusnina A,
Vapalahti O, Elliott RM, Weber F, Vaheri A, Plyusnin A
(2007) Tula and Puumala hantavirus NSs ORFs are function-
al and the products inhibit activation of the interferon-beta
promoter. J Med Virol 79:1527–1536
Jenison S, Yamada T, Morris C, Anderson B, Torrez-Martinez N, Keller
N, Hjelle B (1994) Characterization of human antibody responses to
four corners hantavirus infections among patients with hantavirus
pulmonary syndrome. J Virol 68:3000–3006
Jessie K, Fong MY, Devi S, Lam SK, Wong KT (2004) Localization of
dengue virus in naturally infected human tissues, by immunohisto-
chemistry and in situ hybridization. J Infect Dis 189:1411–1418
630 Cell Tissue Res (2014) 355:621–633
Junjhon J, Lausumpao M, Supasa S, Noisakran S, Songjaeng A,
Saraithong P, Chaichoun K, Utaipat U, Keelapang P,
Kanjanahaluethai A, Puttikhunt C, Kasinrerk W, Malasit P,
Sittisombut N (2008) Differential modulation of prM cleavage,
extracellular particle distribution, and virus infectivity by conserved
residues at nonfurin consensus positions of the dengue virus pr-M
junction. J Virol 82:10776–10791
Junjhon J, Edwards TJ, Utaipat U, Bowman VD, Holdaway HA, Zhang
W, Keelapang P, Puttikhunt C, Perera R, Chipman PR, KasinrerkW,
Malasit P, Kuhn RJ, Sittisombut N (2010) Influence of pr-M cleav-
age on the heterogeneity of extracellular dengue virus particles. J
Virol 84:8353–8358
Kelley JF, Kaufusi PH, Nerurkar VR (2012) Dengue hemorrhagic fever-
associated immunomediators induced via maturation of dengue
virus nonstructural 4B protein in monocytes modulate endothelial
cell adhesion molecules and human microvascular endothelial cells
permeability. Virology 422:326–337
Khaiboullina SF, St Jeor SC (2002) Hantavirus immunology. Viral
Immunol 15:609–625
Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA
(2004) Role of specific CD8+ T cells in the severity of a fulminant
zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J
Immunol 172:3297–3304
Klein SL,Marks MA, LiW, Glass GE, Fang LQ,Ma JQ, CaoWC (2011)
Sex differences in the incidence and case fatality rates from hemor-
rhagic fever with renal syndrome in China, 2004–2008. Clin Infect
Dis 52:1414–1421
Klingstrom J, Plyusnin A, Vaheri A, Lundkvist A (2002) Wild-type
Puumala hantavirus infection induces cytokines, C-reactive protein,
creatinine, and nitric oxide in cynomolgus macaques. J Virol 76:
444–449
Knust B, Macneil A, Rollin PE (2012) Hantavirus pulmonary syndrome
clinical findings: evaluating a surveillance case definition. Vector
Borne Zoonotic Dis 12:393–399
Krautkramer E, Grouls S, Stein N, Reiser J, Zeier M (2011) Pathogenic
old world hantaviruses infect renal glomerular and tubular cells and
induce disassembling of cell-to-cell contacts. J Virol 85:9811–9823
Ksiazek TG, Peters CJ, Rollin PE, Zaki S, Nichol S, Spiropoulou C,
Morzunov S, Feldmann H, Sanchez A, Khan AS et al (1995)
Identification of a new North American hantavirus that causes acute
pulmonary insufficiency. Am J Trop Med Hyg 52:117–123
Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E,
Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS,
Strauss JH (2002) Structure of dengue virus: implications for flavi-
virus organization, maturation, and fusion. Cell 108:717–725
Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E (2006)
Vascular endothelial cadherin controls VEGFR-2 internalization and
signaling from intracellular compartments. J Cell Biol 174:593–604
Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, Tung YC, Lin YS, Yeh TM,
Chen SH, Liu HS (2006) MCP-1, a highly expressed chemokine in
dengue haemorrhagic fever/dengue shock syndrome patients, may
cause permeability change, possibly through reduced tight junctions
of vascular endothelium cells. J Gen Virol 87:3623–3630
Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, Feldmann H
(2010) Antagonism of type I interferon responses by new world
hantaviruses. J Virol 84:11790–11801
Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn
S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman
AL (2002a) Differing influences of virus burden and immune acti-
vation on disease severity in secondary dengue-3 virus infections. J
Infect Dis 185:1213–1221
Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S,
Vaughn DW, Nisalak A, Ennis FA, Rothman AL (2002b) High
circulating levels of the dengue virus nonstructural protein NS1
early in dengue illness correlate with the development of dengue
hemorrhagic fever. J Infect Dis 186:1165–1168
Limonta D, Capo V, Torres G, Perez AB, Guzman MG (2007) Apoptosis
in tissues from fatal dengue shock syndrome. J Clin Virol 40:50–54
Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK, Liu HS, Liu
CC, Anderson R, Lei HY (2011) Molecular mimicry between virus
and host and its implications for dengue disease pathogenesis. Exp
Biol Med (Maywood) 236:515–523
Liu IJ, Chiu CY, Chen YC, Wu HC (2011) Molecular mimicry of human
endothelial cell antigen by autoantibodies to nonstructural protein 1
of dengue virus. J Biol Chem 286:9726–9736
Lundkvist A, Hukic M, Horling J, Gilljam M, Nichol S, Niklasson B
(1997) Puumala and Dobrava viruses cause hemorrhagic fever with
renal syndrome in Bosnia-Herzegovina: evidence of highly cross-
neutralizing antibody responses in early patient sera. J MedVirol 53:
51–59
LuplertlopN,Misse D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn
V, Yssel H, Veas F (2006) Dengue-virus-infected dendritic cells
trigger vascular leakage through metalloproteinase overproduction.
EMBO Rep 7:1176–1181
Ma Y, Liu B, Yuan B, Wang J, Yu H, Zhang Y, Xu Z, Zhang Y, Yi J,
Zhang C, Zhou X, Yang A, Zhuang R, Jin B (2012) Sustained high
level of serum VEGF at convalescent stage contributes to the renal
recovery after HTNV infection in patients with hemorrhagic fever
with renal syndrome. Clin Dev Immunol 2012:812386
MacNeil A, Comer JA, Ksiazek TG, Rollin PE (2010) Sin Nombre virus-
specific immunoglobulin M and G kinetics in hantavirus pulmonary
syndrome and the role played by serologic responses in predicting
disease outcome. J Infect Dis 202:242–246
Macneil A, Nichol ST, Spiropoulou CF (2011) Hantavirus pulmonary
syndrome. Virus Res 162:138–147
Mangada MM, Rothman AL (2005) Altered cytokine responses of
dengue-specific CD4+ T cells to heterologous serotypes. J
Immunol 175:2676–2683
Manigold T, Mori A, Graumann R, Llop E, Simon V, Ferres M,
Valdivieso F, Castillo C, Hjelle B, Vial P (2010) Highly differenti-
ated, resting gn-specific memory CD8+ T cells persist years after
infection by andes hantavirus. PLoS Pathog 6:e1000779
Markotic A, Hensley L, Daddario K, Spik K, Anderson K, Schmaljohn C
(2007) Pathogenic hantaviruses elicit different immunoreactions in
THP-1 cells and primary monocytes and induce differentiation of
humanmonocytes to dendritic-like cells. Coll Anthropol 31:1159–1167
Marsac D, Garcia S, Fournet A, Aguirre A, Pino K, Ferres M, Kalergis
AM, Lopez-Lastra M, Veas F (2011) Infection of human monocyte-
derived dendritic cells by ANDES Hantavirus enhances pro-
inflammatory state, the secretion of active MMP-9 and indirectly
enhances endothelial permeability. Virol J 8:223
Medin CL, Fitzgerald KA, Rothman AL (2005) Dengue virus nonstruc-
tural protein NS5 induces interleukin-8 transcription and secretion. J
Virol 79:11053–11061
Michels M, van der Ven AJ, Djamiatun K, Fijnheer R, de Groot PG,
Griffioen AW, Sebastian S, Faradz SM, deMast Q (2012) Imbalance
of angiopoietin-1 and angiopoetin-2 in severe dengue and relation-
ship with thrombocytopenia, endothelial activation, and vascular
stability. Am J Trop Med Hyg 87:943–946
Milazzo ML, Eyzaguirre EJ, Molina CP, Fulhorst CF (2002) Maporal
viral infection in the Syrian golden hamster: a model of hantavirus
pulmonary syndrome. J Infect Dis 186:1390–1395
Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S,
Tangthawornchaikul N, Chairunsri A, Sawasdivorn S,
Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT,
McMichael A, Malasit P, Screaton G (2003) Original antigenic sin
and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat
Med 9:921–927
Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S,
Avirutnan P, Jairungsri A, Khemnu N, Tangthawornchaikul N,
Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A,
Xu X, Malasit P, Screaton G (2006) T cell responses in dengue
Cell Tissue Res (2014) 355:621–633 631
hemorrhagic fever: are cross-reactive Tcells suboptimal? J Immunol
176:3821–3829
Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE,
Waite DC, Koster FT, Ennis FA (1999) High levels of cytokine-
producing cells in the lung tissues of patients with fatal hantavirus
pulmonary syndrome. J Infect Dis 179:295–302
Morzunov SP, Rowe JE, Ksiazek TG, Peters CJ, St Jeor SC, Nichol ST
(1998) Genetic analysis of the diversity and origin of hantaviruses in
Peromyscus leucopus mice in North America. J Virol 72:57–64
Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L,
Ashok M, Lipkin WI, Garcia-Sastre A (2005) Inhibition of alpha/
beta interferon signaling by the NS4B protein of flaviviruses. J Virol
79:8004–8013
Nasirudeen AM,WongHH, Thien P, Xu S, LamKP, LiuDX (2011) RIG-
I, MDA5 and TLR3 synergistically play an important role in restric-
tion of dengue virus infection. PLoS Negl Trop Dis 5:e926
Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG,
Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ (1993)
Genetic identification of a hantavirus associated with an outbreak
of acute respiratory illness. Science 262:914–917
Niikura M, Maeda A, Ikegami T, Saijo M, Kurane I, Morikawa S (2004)
Modification of endothelial cell functions by Hantaan virus infec-
tion: prolonged hyper-permeability induced by TNF-alpha of
hantaan virus-infected endothelial cell monolayers. Arch Virol
149:1279–1292
Nimmannitya S (1993) Clinical manifestations of Dengue/Dengue
Haemorrhagic Fever. In: Thongcharoen P (ed) Monograph on
Dengue/Dengue Haemorrhagic Fever. World Health Organization,
New Delhi, pp 48–57
Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, Madar D, Merlin
TL, McFeeley PJ, Umland ET, Zumwalt RE (1995) Hantavirus pulmo-
nary syndrome in the United States: a pathological description of a
disease caused by a new agent. Hum Pathol 26:110–120
Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi
SA, Sukhatme VP (2006) Excess circulating angiopoietin-2 may
contribute to pulmonary vascular leak in sepsis in humans. PLoS
Med 3:e46
Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J (1992) Hantaan
virus infection of human endothelial cells. J Virol 66:5929–5936
Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, AlvarezM, Sanchez L,
Valdes L, Volk HD, Guzman MG (2010) Tumor necrosis factor-
alpha, transforming growth factor-beta1, and interleukin-10 gene
polymorphisms: implication in protection or susceptibility to dengue
hemorrhagic fever. Hum Immunol 71:1135–1140
Plyusnin A (2002) Genetics of hantaviruses: implications to taxonomy.
Arch Virol 147:665–682
Prescott J, Safronetz D, Haddock E, Robertson S, Scott D, Feldmann H
(2013) The adaptive immune response does not influence hantavirus
disease or persistence in the Syrian hamster. Immunology 140:168–178
Raftery MJ, Kraus AA, Ulrich R, Kruger DH, Schonrich G (2002)
Hantavirus infection of dendritic cells. J Virol 76:10724–10733
Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans
N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, Kain
KC, Liaw PC, Liles WC (2011) Angiopoietin-1 and angiopoietin-2
as clinically informative prognostic biomarkers of morbidity and
mortality in severe sepsis. Crit Care Med 39:702–710
Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der
Ende-Metselaar H, Lei HY, Wilschut J, Smit JM (2010) Immature
dengue virus: a veiled pathogen? PLoS Pathog 6:e1000718
Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K,
Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W,
Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A,
Viviani S, Tornieporth NG, Lang J (2012) Protective efficacy of the
recombinant, live-attenuated, CYD tetravalent dengue vaccine in
Thai schoolchildren: a randomised, controlled phase 2b trial.
Lancet 380:1559–1567
Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A,
Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM,
Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S,
Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P,
Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM,
Malasit P, Despres P, Julier C (2005) A variant in the CD209
promoter is associated with severity of dengue disease. Nat Genet
37:507–513
Schmaljohn C, Hjelle B (1997) Hantaviruses: a global disease problem.
Emerg Infect Dis 3:95–104
Schmaljohn CS, Nichol ST (2007) Bunyaviridae. In: Fields DMK BN,
Howley PM (eds) Fields Virology, 5th edn. Lippincott-Raven,
Philadelphia, pp 1741–1789
Settergren B (1991) Hantavirus infection and renal failure. Lancet 337:
549–550
Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E (2006) Murine
model for dengue virus-induced lethal disease with increased vas-
cular permeability. J Virol 80:10208–10217
Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF (2010) Andes virus
disrupts the endothelial cell barrier by induction of vascular endo-
thelial growth factor and downregulation of VE-cadherin. J Virol 84:
11227–11234
Sironen T, Klingstrom J, Vaheri A, Andersson LC, Lundkvist A, Plyusnin
A (2008) Pathology of Puumala hantavirus infection in macaques.
PLoS ONE 3:e3035
Spiropoulou CF,Morzunov S, FeldmannH, Sanchez A, Peters CJ, Nichol
ST (1994) Genome structure and variability of a virus causing
hantavirus pulmonary syndrome. Virology 200:715–723
Spiropoulou CF, Albarino CG, Ksiazek TG, Rollin PE (2007) Andes and
Prospect Hill hantaviruses differ in early induction of interferon
although both can downregulate interferon signaling. J Virol 81:
2769–2776
Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S,
Libraty DH, Green S, Ennis FA, Rothman AL (2007) Virus-
induced decline in soluble vascular endothelial growth recep-
tor 2 is associated with plasma leakage in dengue hemor-
rhagic Fever. J Virol 81:1592–1600
Srikiatkhachorn A, Wichit S, Gibbons RV, Green S, Libraty DH, Endy
TP, Ennis FA, Kalayanarooj S, Rothman AL (2012) Dengue viral
RNA levels in peripheral blood mononuclear cells are associated
with disease severity and preexisting dengue immune status. PLoS
ONE 7:e51335
Stephens HA (2010) HLA and other gene associations with dengue
disease severity. Curr Top Microbiol Immunol 338:99–114
Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S,
Kalayanarooj S, Endy TP, Libraty DH, Nisalak A, Innis BL,
Rothman AL, Ennis FA, Chandanayingyong D (2002) HLA-A
and -B allele associations with secondary dengue virus infections
correlate with disease severity and the infecting viral serotype in
ethnic Thais. Tissue Antigens 60:309–318
Sun DS, King CC, Huang HS, Shih YL, Lee CC, TsaiWJ, Yu CC, Chang
HH (2007) Antiplatelet autoantibodies elicited by dengue virus non-
structural protein 1 cause thrombocytopenia and mortality in mice. J
Thromb Haemost 5:2291–2299
Sundstrom JB, McMullan LK, Spiropoulou CF, Hooper WC, Ansari AA,
Peters CJ, Rollin PE (2001) Hantavirus infection induces the ex-
pression of RANTES and IP-10 without causing increased perme-
ability in human lung microvascular endothelial cells. J Virol 75:
6070–6085
Surasombatpattana P, Hamel R, Patramool S, Luplertlop N,
Thomas F, Despres P, Briant L, Yssel H, Misse D (2011)
Dengue virus replication in infected human keratinocytes
leads to activation of antiviral innate immune responses.
Infect Genet Evol 11:1664–1673
Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C,
Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S,
632 Cell Tissue Res (2014) 355:621–633
Birx DL, Steinman RM, Schlesinger S, Marovich MA (2003) DC-
SIGN (CD209) mediates dengue virus infection of human dendritic
cells. J Exp Med 197:823–829
Taylor SL, Frias-Staheli N, Garcia-Sastre A, Schmaljohn CS (2009a)
Hantaan virus nucleocapsid protein binds to importin alpha proteins
and inhibits tumor necrosis factor alpha-induced activation of nu-
clear factor kappa B. J Virol 83:1271–1279
Taylor SL, Krempel RL, Schmaljohn CS (2009b) Inhibition of TNF-
alpha-induced activation of NF-kappaB by hantavirus nucleocapsid
proteins. Ann NYAcad Sci 1171(Suppl 1):E86–E93
Taylor SL, Wahl-Jensen V, Copeland AM, Jahrling PB, Schmaljohn CS
(2013) Endothelial cell permeability during hantavirus infection
involves factor XII-dependent increased activation of the
kallikrein-kinin system. PLoS Pathog 9:e1003470
Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthofer H
(1996) Cytokines, adhesion molecules, and cellular infiltration in
nephropathia epidemica kidneys: an immunohistochemical study.
Clin Immunol Immunopathol 78:47–55
Terajima M, Ennis FA (2011) T cells and pathogenesis of hantavirus
cardiopulmonary syndrome and hemorrhagic fever with renal syn-
drome. Viruses 3:1059–1073
Terajima M, Vapalahti O, Van Epps HL, Vaheri A, Ennis FA (2004)
Immune responses to Puumala virus infection and the pathogenesis
of nephropathia epidemica. Microbes Infect Inst Pasteur 6:238–245
Trung DT, Wills B (2010) Systemic vascular leakage associated with
dengue infections - the clinical perspective. Curr Top Microbiol
Immunol 338:57–66
Ubol S, Phuklia W, Kalayanarooj S, Modhiran N (2010)
Mechanisms of immune evasion induced by a complex of
dengue virus and preexisting enhancing antibodies. J Infect
Dis 201:923–935
Valdivieso F, Vial P, Ferres M, Ye C, Goade D, Cuiza A, Hjelle B (2006)
Neutralizing antibodies in survivors of Sin Nombre and Andes
hantavirus infection. Emerg Infect Dis 12:166–168
Van Epps HL, Schmaljohn CS, Ennis FA (1999) Human memory cyto-
toxic T-lymphocyte (CTL) responses to Hantaan virus infection:
identification of virus-specific and cross-reactive CD8(+) CTL epi-
topes on nucleocapsid protein. J Virol 73:5301–5308
Van Epps HL, Terajima M, Mustonen J, Arstila TP, Corey EA, Vaheri A,
Ennis FA (2002) Long-lived memory T lymphocyte responses after
hantavirus infection. J Exp Med 196:579–588
Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S,
Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis
FA, Nisalak A (2000) Dengue viremia titer, antibody response
pattern, and virus serotype correlate with disease severity. J Infect
Dis 181:2–9
Wang S, Zang L, Feng M, Liang Z, Zheng S, Zhang L, Jiang Z, Chen D
(1997) Transmission electron microscopic study of the hemorrhagic
spots in patients with epidemic hemorrhagic fever in the early stage.
Ultrastruct Pathol 21:281–287
Wu-Hsieh BA, Yen YT, Chen HC (2009) Dengue hemorrhage in a mouse
model. Ann NYAcad Sci 1171(Suppl 1):E42–E47
Xiao K, Allison DF, Kottke MD, Summers S, Sorescu GP, Faundez V,
Kowalczyk AP (2003) Mechanisms of VE-cadherin processing and
degradation in microvascular endothelial cells. J Biol Chem 278:
19199–19208
Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL
(2012) Dengue virus targets the adaptor protein MITA to subvert
host innate immunity. PLoS Pathog 8:e1002780
Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K,
Feddersen RM, Zumwalt RE, Miller GL, Khan AS et al (1995)
Hantavirus pulmonary syndrome. Pathogenesis of an emerging in-
fectious disease. Am J Pathol 146:552–579
Zaki SR, Khan AS, Goodman RA, Armstrong LR, Greer PW, Coffield
LM, Ksiazek TG, Rollin PE, Peters CJ, Khabbaz RF (1996)
Retrospective diagnosis of hantavirus pulmonary syndrome, 1978–
1993: implications for emerging infectious diseases. Arch Pathol
Lab Med 120:134–139
Zhang JL,Wang JL, Gao N, Chen ZT, Tian YP, An J (2007) Up-regulated
expression of beta3 integrin induced by dengue virus serotype 2
infection associated with virus entry into human dermal microvascu-
lar endothelial cells. Biochem Biophys Res Commun 356:763–768
Cell Tissue Res (2014) 355:621–633 633
